The fluorescence signal intensity is much smaller than for Fig. 3a showing that HER2 labelling of cells in a tumour classified as HER2 positive indeed leads to signal that is distinguishable from HER2 negatively classified samples, and thus verifies the specificity of the method. This evidence concerns the gene ERBB2 and neoplasm.